4//SEC Filing
Henderson Jane 4
Accession 0001104659-25-111631
CIK 0001974640other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:37 PM ET
Size
5.0 KB
Accession
0001104659-25-111631
Insider Transaction Report
Form 4
Henderson Jane
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-11$60.00/sh−1,000$60,000→ 199,871 total
Footnotes (1)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.
Documents
Issuer
Apogee Therapeutics, Inc.
CIK 0001974640
Entity typeother
Related Parties
1- filerCIK 0001422304
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:37 PM ET
- Size
- 5.0 KB